Maxim A. Shorikov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maxim A. Shorikov has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Boris I. Dolgushin
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
4 shared publications - Aleksandr N. Polyakov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
3 shared publications - D. Yu. Frantsev
N.N. Blokhin National Medical Research Center of Oncology
3 shared publications Д. Ю. Францев
Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина Минздрава России
3 shared publications- A. L. Nikulina
N.N. Blokhin National Medical Research Centre of Oncology, Ministry of Health of Russia
2 shared publications - Ekaterina A. Petrash
Pirogov Russian National Research Medical University
2 shared publications
Latest Publications
- Open Access
- 29 March 2024
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 7 (1) , 41-61
Magnetic Resonance Imaging in Objective Response Evaluation in Klatskin Tumor Patients after Endobiliary Photodynamic Therapy
Purpose: Visualization of periductal infiltrative hilar cholangiocarcinomas in general and their changes in response to endobiliary photodynamic therapy (PDT) in particular is not an easy diagnostic task because of their small size, infiltrative growth pattern, and absence of clearly circumscribed margins with adjacent tissue. This caused most researchers to give up the study of criteria for objective response to locoregional treatment, and to use only the survival rate as performance criteria. The aim of this study is to determine the criteria of objective response in Klatskin tumor after PDT based on the analysis of preand postoperative MRI.Material and methods: The study covered 42 patients (26 male (62 %) and 16 female (38 %)) with morphologically verified Klatskin tumor aged 21-76 (median 55) after 104 sessions (from 1 to 10, median 2) of percutaneous endobiliary PDT over the period of 2007-2020. All patients had percutaneous transhepatic or intraoperative drainage of bile ducts from 1 week to 2 years before PDT. Chlorine photosensitizers were used for PDT. The LAHTA-MILON programmable laser unit with 662 nm wavelength was used for photo-irradiation. The specific dose varied from 4.6 to 232,2 J/cm2 (median 29) and the total dose was 64.6-3890 J (median 950), depending on the extent of lesion and the patient’s tolerance to interventions. 220 abdominal MRI were done at various times before and after PDT. Preoperative MRI were completed 1-101 days (median 13.5 days) before the intervention. Postoperative MRI scans were split into groups based on the time following the intervention: 1) after 1–5 days, 2) after 2 months, 3) after 3 months, and 4) after 4 months. Examinations were carried out with the Siemens Magnetom Avanto/Espree 1.5 Tesla MRI scanner. To compare the indicators at different times, the Kruskal–Wallis test was used, p < 0.05 were considered significant.Results: As a result of the analysis, the following statistically significant changes in the Klatskin tumor after PDT were obtained at various times: the largest transverse size of the tumor infiltrate decrease at the proximal hepaticocholedochus level 1 month after PDT; the infiltrate longitudinal size increase at the bile ducts confluence level 4 month after PDT; T2-WI signal intensity increase at the photodynamic area in 1–5 days after PDT; T1-WI signal intensity decrease in various contrasting phases at the photodynamic area in 1–5 days after PDT; ADC signal intensity increase at the photodynamic and conditionally healthy tissues areas 1 month after PDT; T1-WI signal intensity increase in venous and delayed contrasting phases at the photodynamic area 1 month after PDT; T1-WI signal intensity decrease in porto-venous and delayed contrasting phases at the photodynamic area 2 month after PDT; ADC signal intensity decrease at conditionally healthy tissues 4 month after PDT.Conclusion: Changes in MR signal intensity after endobiliary PDT with different pulse sequences (DWI + ADC, T2-WI with and without suppression of signal from adipose tissue, T1-WI before and after intravenous injection of contrast agent in 4 phases of contrasting) in pathological and conditionally healthy intraand periductal tissues and the tumor dimensions (largest crosssectional dimensions and thickness measured in axial and coronal projections in T2-WI) may be used as the criteria of objective response. Determination in the early postoperative period of periductal segments in the area of photodynamic treatment that do not accumulate contrast agent is the most informative, displayable and convenient for practical use criterion of objective response indicating the ischemia of tumor tissue.
- 29 March 2024
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 7 (1) , 41-61
Open AccessMagnetic Resonance Imaging in Objective Response Evaluation in Klatskin Tumor Patients after Endobiliary Photodynamic Therapy
Purpose: Visualization of periductal infiltrative hilar cholangiocarcinomas in general and their changes in response to endobiliary photodynamic therapy (PDT) in particular is not an easy diagnostic task because of their small size, infiltrative growth pattern, and absence of clearly circumscribed margins with adjacent tissue. This caused most researchers to give up the study of criteria for objective response to locoregional treatment, and to use only the survival rate as performance criteria. The aim of this study is to determine the criteria of objective response in Klatskin tumor after PDT based on the analysis of preand postoperative MRI.Material and methods: The study covered 42 patients (26 male (62 %) and 16 female (38 %)) with morphologically verified Klatskin tumor aged 21-76 (median 55) after 104 sessions (from 1 to 10, median 2) of percutaneous endobiliary PDT over the period of 2007-2020. All patients had percutaneous transhepatic or intraoperative drainage of bile ducts from 1 week to 2 years before PDT. Chlorine photosensitizers were used for PDT. The LAHTA-MILON programmable laser unit with 662 nm wavelength was used for photo-irradiation. The specific dose varied from 4.6 to 232,2 J/cm2 (median 29) and the total dose was 64.6-3890 J (median 950), depending on the extent of lesion and the patient’s tolerance to interventions. 220 abdominal MRI were done at various times before and after PDT. Preoperative MRI were completed 1-101 days (median 13.5 days) before the intervention. Postoperative MRI scans were split into groups based on the time following the intervention: 1) after 1–5 days, 2) after 2 months, 3) after 3 months, and 4) after 4 months. Examinations were carried out with the Siemens Magnetom Avanto/Espree 1.5 Tesla MRI scanner. To compare the indicators at different times, the Kruskal–Wallis test was used, p < 0.05 were considered significant.Results: As a result of the analysis, the following statistically significant changes in the Klatskin tumor after PDT were obtained at various times: the largest transverse size of the tumor infiltrate decrease at the proximal hepaticocholedochus level 1 month after PDT; the infiltrate longitudinal size increase at the bile ducts confluence level 4 month after PDT; T2-WI signal intensity increase at the photodynamic area in 1–5 days after PDT; T1-WI signal intensity decrease in various contrasting phases at the photodynamic area in 1–5 days after PDT; ADC signal intensity increase at the photodynamic and conditionally healthy tissues areas 1 month after PDT; T1-WI signal intensity increase in venous and delayed contrasting phases at the photodynamic area 1 month after PDT; T1-WI signal intensity decrease in porto-venous and delayed contrasting phases at the photodynamic area 2 month after PDT; ADC signal intensity decrease at conditionally healthy tissues 4 month after PDT.Conclusion: Changes in MR signal intensity after endobiliary PDT with different pulse sequences (DWI + ADC, T2-WI with and without suppression of signal from adipose tissue, T1-WI before and after intravenous injection of contrast agent in 4 phases of contrasting) in pathological and conditionally healthy intraand periductal tissues and the tumor dimensions (largest crosssectional dimensions and thickness measured in axial and coronal projections in T2-WI) may be used as the criteria of objective response. Determination in the early postoperative period of periductal segments in the area of photodynamic treatment that do not accumulate contrast agent is the most informative, displayable and convenient for practical use criterion of objective response indicating the ischemia of tumor tissue.
- Open Access
- 18 July 2023
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (2) , 63-70
Differential diagnosis of benign and malignant liver tumors in children using the method of quantitative assessment of multiparametric magnetic resonance imaging data
Introduction. Liver tumors account for 1.1 % of all newly diagnosed neoplasms in children. The rarity of this pathology causes difficulties in differential diagnosis. Currently, magnetic resonance imaging (MRI) is the main and most promising method for diagnosing liver diseases. In our work, we decided to quantify the data from this study.Purpose of the study – determination of the possibilities of quantitative assessment of multiparametric MRI data in the differential diagnosis of benign and malignant liver tumors in children.Material and methods. 133 patients with 307 liver lesions aged from 5 months to 20 years were examined. All patients underwent MRI on high-field MRI machines using an extracellular contrast agent, which included T2 weighted images with and without suppression of the signal from adipose tissue, diffusion-weighted images with automatic calculation of maps of the apparent diffusion coefficient (ADC), T1 weighted images with suppression of the signal from adipose tissue before and after the introduction of a contrast agent (in the arterial, portal, venous and delayed phases). Quantitative characteristics of changes in signal intensity in the lesion, intact liver parenchyma, spleen, kidney, aorta, and inferior vena cava (IVC) were obtained. To level the influence of external factors, we used not the absolute values of the signal intensity, but the ratios: lesion/intact liver parenchyma, lesion/kidney, lesion/aorta, lesion/spleen, lesion/IVC. For each lesion, 5 coefficients were calculated in each of the sequences, with the exception of patients (n = 4) after splenectomy, in whom 4 coefficients were calculated. In addition, for images obtained after the injection of a contrast agent, the ratios of the signal on post-contrast images to the native phase were calculated. Quantitative parameters such as the maximum size of the tumor, its volume and the age of the patient were included in the calculation. Tumors were represented by benign (n = 139) and malignant (n = 169) formations. The diagnosis of all malignant neoplasms and some benign ones was confirmed morphologically, benign ones – using MRI with intravenous contrast and dynamic observation.Results. A mathematical model was built:A = 1/(1+e-Z),where Z = 6,25019 + 1,03132 × S + 1,30077 × P2le/li – 0,00459 × DCle + 4,01375 × P1le/a – 2,05533 × Part le/li – 2,55823 × Pport le/k + 7,56980 × Pdel5 le/k – 15,91047 × Pdel5 le/a.The model is informative and statistically significant (p < 0.001). If A > 0.5, it should be considered that the studied focus is of a malignant nature, if A ≤ 0.5, the formation is benign. Model sensitivity and specificity were, respectively, 0.947 and 0.917.Conclusion. The mathematical model makes it possible to differentiate between malignant and benign formations with a high degree of informativeness, which is a priority task in detecting a mass formation in the liver.
- 18 July 2023
- Published by OOO Grafika in Russian Journal of Pediatric Hematology and Oncology
- Vol. 10 (2) , 63-70
Open AccessDifferential diagnosis of benign and malignant liver tumors in children using the method of quantitative assessment of multiparametric magnetic resonance imaging data
Introduction. Liver tumors account for 1.1 % of all newly diagnosed neoplasms in children. The rarity of this pathology causes difficulties in differential diagnosis. Currently, magnetic resonance imaging (MRI) is the main and most promising method for diagnosing liver diseases. In our work, we decided to quantify the data from this study.Purpose of the study – determination of the possibilities of quantitative assessment of multiparametric MRI data in the differential diagnosis of benign and malignant liver tumors in children.Material and methods. 133 patients with 307 liver lesions aged from 5 months to 20 years were examined. All patients underwent MRI on high-field MRI machines using an extracellular contrast agent, which included T2 weighted images with and without suppression of the signal from adipose tissue, diffusion-weighted images with automatic calculation of maps of the apparent diffusion coefficient (ADC), T1 weighted images with suppression of the signal from adipose tissue before and after the introduction of a contrast agent (in the arterial, portal, venous and delayed phases). Quantitative characteristics of changes in signal intensity in the lesion, intact liver parenchyma, spleen, kidney, aorta, and inferior vena cava (IVC) were obtained. To level the influence of external factors, we used not the absolute values of the signal intensity, but the ratios: lesion/intact liver parenchyma, lesion/kidney, lesion/aorta, lesion/spleen, lesion/IVC. For each lesion, 5 coefficients were calculated in each of the sequences, with the exception of patients (n = 4) after splenectomy, in whom 4 coefficients were calculated. In addition, for images obtained after the injection of a contrast agent, the ratios of the signal on post-contrast images to the native phase were calculated. Quantitative parameters such as the maximum size of the tumor, its volume and the age of the patient were included in the calculation. Tumors were represented by benign (n = 139) and malignant (n = 169) formations. The diagnosis of all malignant neoplasms and some benign ones was confirmed morphologically, benign ones – using MRI with intravenous contrast and dynamic observation.Results. A mathematical model was built:A = 1/(1+e-Z),where Z = 6,25019 + 1,03132 × S + 1,30077 × P2le/li – 0,00459 × DCle + 4,01375 × P1le/a – 2,05533 × Part le/li – 2,55823 × Pport le/k + 7,56980 × Pdel5 le/k – 15,91047 × Pdel5 le/a.The model is informative and statistically significant (p < 0.001). If A > 0.5, it should be considered that the studied focus is of a malignant nature, if A ≤ 0.5, the formation is benign. Model sensitivity and specificity were, respectively, 0.947 and 0.917.Conclusion. The mathematical model makes it possible to differentiate between malignant and benign formations with a high degree of informativeness, which is a priority task in detecting a mass formation in the liver.
- Open Access
- 15 April 2022
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (1) , 5-13
Sex differences in the connectome of the human brain according to an MR-tractography study
Background: The gender differences in the brain anatomy play an important role in planning and analysis in a lot of studies of the brain. Despite most animal studies being performed on the animals of only one sex, clinical studies generally enroll both males and females. Keeping this fact in mind, learning the gender differences in the white matter structure is important for those studies which deal with the white matter changes. These differences should be considered on the stages of planning and evaluation of the results. Aims: Evaluation of the gender differences in the white matter pathways in healthy subjects. Methods: 21 women and 20 men were enrolled in the study. All the subjects underwent MR-tractography, then the anatomic connectome was composed and the differences were evaluated using the tracts quantitative anisotropy (QA) evaluation. Results: The gender differences were found in the white matter pathways with the prevalence of quantitative anisotropy in women, observed in a larger number of tracts than in those of men. QA was prevalent in a lot of fascicli that form major pathways in both groups: corpus callosum, dominant arcuate fasciclus, inferior fronto-occipital, inferior and superior right longitudinal pathways. Conclusions: The white matter pathways in males and females are different not only within the major tracts but also for small fascicli that form tracts.
- 15 April 2022
- Published by ECO-Vector LLC in Journal of Clinical Practice
- Vol. 13 (1) , 5-13
Open AccessSex differences in the connectome of the human brain according to an MR-tractography study
Background: The gender differences in the brain anatomy play an important role in planning and analysis in a lot of studies of the brain. Despite most animal studies being performed on the animals of only one sex, clinical studies generally enroll both males and females. Keeping this fact in mind, learning the gender differences in the white matter structure is important for those studies which deal with the white matter changes. These differences should be considered on the stages of planning and evaluation of the results. Aims: Evaluation of the gender differences in the white matter pathways in healthy subjects. Methods: 21 women and 20 men were enrolled in the study. All the subjects underwent MR-tractography, then the anatomic connectome was composed and the differences were evaluated using the tracts quantitative anisotropy (QA) evaluation. Results: The gender differences were found in the white matter pathways with the prevalence of quantitative anisotropy in women, observed in a larger number of tracts than in those of men. QA was prevalent in a lot of fascicli that form major pathways in both groups: corpus callosum, dominant arcuate fasciclus, inferior fronto-occipital, inferior and superior right longitudinal pathways. Conclusions: The white matter pathways in males and females are different not only within the major tracts but also for small fascicli that form tracts.
- Open Access
- 1 October 2021
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 4 (3) , 56-63
Differential Diagnosis of Benign and Malignant Level Tumors in Children by Quantitative MRI with Intracellular Contrast Agent
Purpose: Тo determine the possibilities of quantitative assessment of mpMRI with EOB-DTPA in the differential diagnosis of benign and malignant tumors in children.Material and methods: 30 patients (male — 17, female — 13) with 83 tumors underwent MRI. Age ranged from 5 months to 20 years. All children underwent MRI on 3T or 1.5T MR-scanners using body coil. Fat saturated T1WI were performed before and after hepatotropic MR-contrast agent (gadoxetic acid) injection in arterial, portal, venous and delayed phases (1, 5, 20, 40 min). Tumors were divided into 2 groups: benign (52) and malignant (31). In this work we use only pre- and postcontrast T1WI. Diagnosis was confirmed histologically (all malignant and a part of benign FLL) and long-term MRI follow-up studies (for benign). To eliminate influence of external factors we used coefficients for each MR-program, the signal was normalized to intact liver parenchyma, spleen, abdominal aorta and v. cava inferior, also normalization to native series has been performed. Coefficients were compared for malignant and benign tumors using Student’s t-test, significantly different parameters were further used to build mathematical model by constructing a logistic regression with step-by-step selection of the most informative values.Results: Regression model is presented by formula. The model is informative and statistically significant (p < 0.001). If A>0.5 tumors has a malignant nature if А ≤ 0.5–benign. Model sensitivity and specificity are 0.862 and 0.925, respectively.Conclusion: Our model could be an excellent assistance in differentiation of benign and malignant focal liver lesions and reduces diagnostic path, effects the proper patients management.
- 1 October 2021
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 4 (3) , 56-63
Open AccessDifferential Diagnosis of Benign and Malignant Level Tumors in Children by Quantitative MRI with Intracellular Contrast Agent
Purpose: Тo determine the possibilities of quantitative assessment of mpMRI with EOB-DTPA in the differential diagnosis of benign and malignant tumors in children.Material and methods: 30 patients (male — 17, female — 13) with 83 tumors underwent MRI. Age ranged from 5 months to 20 years. All children underwent MRI on 3T or 1.5T MR-scanners using body coil. Fat saturated T1WI were performed before and after hepatotropic MR-contrast agent (gadoxetic acid) injection in arterial, portal, venous and delayed phases (1, 5, 20, 40 min). Tumors were divided into 2 groups: benign (52) and malignant (31). In this work we use only pre- and postcontrast T1WI. Diagnosis was confirmed histologically (all malignant and a part of benign FLL) and long-term MRI follow-up studies (for benign). To eliminate influence of external factors we used coefficients for each MR-program, the signal was normalized to intact liver parenchyma, spleen, abdominal aorta and v. cava inferior, also normalization to native series has been performed. Coefficients were compared for malignant and benign tumors using Student’s t-test, significantly different parameters were further used to build mathematical model by constructing a logistic regression with step-by-step selection of the most informative values.Results: Regression model is presented by formula. The model is informative and statistically significant (p < 0.001). If A>0.5 tumors has a malignant nature if А ≤ 0.5–benign. Model sensitivity and specificity are 0.862 and 0.925, respectively.Conclusion: Our model could be an excellent assistance in differentiation of benign and malignant focal liver lesions and reduces diagnostic path, effects the proper patients management.
- Open Access
- 31 December 2020
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 3 (4) , 39-50
The MRI-Hallmarks of Liver Neroendocrine Metastases with Different Localization of Primary Neroendocrine Tumor
Purpose: To identify the MRI-hallmarks of liver metastatic neuroendocrine tumors (mNETs) with different localization of primary tumor.Material and methods: 75 liver mNET patients were enrolled in the study. The hepatic metastasis patients were divided into two groups: with pancreatic mNETs (n = 37) and with gastrointestinal tract (gut) mNETs (n = 38), including those of a stomach, small and large bowel, and appendicular primary. All patients underwent abdominal contrast-enhanced MRI with the measurement: the number and the maximum size of the lesions, the presence and size of avascular zones in the lesions, the presence of MRI signs of hemoglobin deg-radation products. In the region of interest, which corresponded to a rounded section in the solid portions of metastases, were measured quantitative indicators of signal intensity on T2-weighted images (WI), native and post-contrast T1-WI, the degree of accumulation of MR contrast agent (MRCA) and its washout, the value of apparent diffusion coefficient (ADC). A total of 171 lesions were assessed. The data were compared in the varying localization of the primary NET groups of patients.Results: The study demonstrated that the solid portion of the gut mNETs compared with that of the pancreatic mNETs are characterized by lower ADC-value (p = 0.0102, medians: pancreatic mNETs — 1036 × 10–3 mm2/s, gut mNETs — 846 × 10–3 mm2/s), less active accumulation of MRCA on the arterial (p = 0.0002, medians: pan-creatic mNETs — 1.48, gut mNETs — 1.24) and venous (p = 0.0026, median: pancreatic mNETs — 2.22, gut mNETs — 1.9) phases of contrast enhancement, longer washout of MRCA (p = 0.0057, median: pan-creas mNETs — 0.92, gut mNETs — 0.98). Based on regression-factor analysis, a model for determining the localization of primary tumors based on MRI signs of liver mNETs was created with an accuracy of 93.8 %.Conclusion: Gut mNETs compared with that of the pancreatic mNETs are characterized by lower ADC-value, less active accumulation and longer washout of MRCA. The data can be used to draw up a personalized examination plan of patient with liver mNETs from the unknown primary.
- 31 December 2020
- Published by Non-profit partnership Society of Interventional Oncoradiologists in Journal of oncology: diagnostic radiology and radiotherapy
- Vol. 3 (4) , 39-50
Open AccessThe MRI-Hallmarks of Liver Neroendocrine Metastases with Different Localization of Primary Neroendocrine Tumor
Purpose: To identify the MRI-hallmarks of liver metastatic neuroendocrine tumors (mNETs) with different localization of primary tumor.Material and methods: 75 liver mNET patients were enrolled in the study. The hepatic metastasis patients were divided into two groups: with pancreatic mNETs (n = 37) and with gastrointestinal tract (gut) mNETs (n = 38), including those of a stomach, small and large bowel, and appendicular primary. All patients underwent abdominal contrast-enhanced MRI with the measurement: the number and the maximum size of the lesions, the presence and size of avascular zones in the lesions, the presence of MRI signs of hemoglobin deg-radation products. In the region of interest, which corresponded to a rounded section in the solid portions of metastases, were measured quantitative indicators of signal intensity on T2-weighted images (WI), native and post-contrast T1-WI, the degree of accumulation of MR contrast agent (MRCA) and its washout, the value of apparent diffusion coefficient (ADC). A total of 171 lesions were assessed. The data were compared in the varying localization of the primary NET groups of patients.Results: The study demonstrated that the solid portion of the gut mNETs compared with that of the pancreatic mNETs are characterized by lower ADC-value (p = 0.0102, medians: pancreatic mNETs — 1036 × 10–3 mm2/s, gut mNETs — 846 × 10–3 mm2/s), less active accumulation of MRCA on the arterial (p = 0.0002, medians: pan-creatic mNETs — 1.48, gut mNETs — 1.24) and venous (p = 0.0026, median: pancreatic mNETs — 2.22, gut mNETs — 1.9) phases of contrast enhancement, longer washout of MRCA (p = 0.0057, median: pan-creas mNETs — 0.92, gut mNETs — 0.98). Based on regression-factor analysis, a model for determining the localization of primary tumors based on MRI signs of liver mNETs was created with an accuracy of 93.8 %.Conclusion: Gut mNETs compared with that of the pancreatic mNETs are characterized by lower ADC-value, less active accumulation and longer washout of MRCA. The data can be used to draw up a personalized examination plan of patient with liver mNETs from the unknown primary.
- Open Access
- 20 September 2020
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 25 (3) , 123-130
Combined treatment options for resectable common bile duct cancer patients
Комбинированное лечение больных резектабельным раком общего желчного протока
- 20 September 2020
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 25 (3) , 123-130
Open AccessCombined treatment options for resectable common bile duct cancer patients
Комбинированное лечение больных резектабельным раком общего желчного протока
- 9 September 2019
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 100 (4) , 200-208
Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases
Objective. To compare liver function assessments using Gd-EOB-DTPA-enhanced MRI and the gold standard hepatobiliary scintigraphy (HBS) in patients with bile duct diseases.Material and methods. The investigation enrolled 18 patients (male/female = 11/7; age, 29–70 years, Klatskin tumor (n=16), bile duct epithelial dysplasia (n=1), intrahepatic cholangiolithiasis (n=1)) after biliary decompression, who underwent 21 paired MRIs and 99mTc-mebrofenin HBS at a study interval of no more than 3 days. In the same regions of interest with a size of 30–50 pixels located in liver segments II–III, IV, V–VIII, and VI–VII, a MRI signal was measured before MR contrast agent (MRCA) injection into the standard vascular phases and at 10, 20, 30 and 40 minutes, then the signal was expressed as a percentage of intensity compared to the precontrast series. After MR volumetry, the functional volumes of the left and right liver lobes were also defined as the area under the MRCA accumulation curve, which was multiplied by the lobe volume and expressed as a percentage of the similarly calculated function of the entire liver. Similar intensity parameters and functional volumes were estimated for a HBS study.Results. The lobe functional volumes measured by the two methods were highly correlated (R=0.8; p0.3). The excretion rate of 99mTc-mebrofenin was also highly correlated with MRI findings (R=0.5–0.9; pConclusion. Gd-EOB-DTPA-enhanced MRI revealed a high correlation with the gold standard; however, additional studies are needed to clarify the possibilities and limitations of replacing one method with another one.
- 9 September 2019
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 100 (4) , 200-208
Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases
Objective. To compare liver function assessments using Gd-EOB-DTPA-enhanced MRI and the gold standard hepatobiliary scintigraphy (HBS) in patients with bile duct diseases.Material and methods. The investigation enrolled 18 patients (male/female = 11/7; age, 29–70 years, Klatskin tumor (n=16), bile duct epithelial dysplasia (n=1), intrahepatic cholangiolithiasis (n=1)) after biliary decompression, who underwent 21 paired MRIs and 99mTc-mebrofenin HBS at a study interval of no more than 3 days. In the same regions of interest with a size of 30–50 pixels located in liver segments II–III, IV, V–VIII, and VI–VII, a MRI signal was measured before MR contrast agent (MRCA) injection into the standard vascular phases and at 10, 20, 30 and 40 minutes, then the signal was expressed as a percentage of intensity compared to the precontrast series. After MR volumetry, the functional volumes of the left and right liver lobes were also defined as the area under the MRCA accumulation curve, which was multiplied by the lobe volume and expressed as a percentage of the similarly calculated function of the entire liver. Similar intensity parameters and functional volumes were estimated for a HBS study.Results. The lobe functional volumes measured by the two methods were highly correlated (R=0.8; p0.3). The excretion rate of 99mTc-mebrofenin was also highly correlated with MRI findings (R=0.5–0.9; pConclusion. Gd-EOB-DTPA-enhanced MRI revealed a high correlation with the gold standard; however, additional studies are needed to clarify the possibilities and limitations of replacing one method with another one.
- Open Access
- 30 May 2018
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 99 (2) , 91-100
POSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
ВОЗМОЖНОСТИ МУЛЬТИПАРАМЕТРИЧЕСКОЙ МАГНИТНО-РЕЗОНАНСНОЙ ТОМОГРАФИИ В ПЕРСОНАЛИЗАЦИИ «СПАСИТЕЛЬНОЙ» ЛУЧЕВОЙ ТЕРАПИИ УБОЛЬНЫХ С РЕЦИДИВОМ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ
- 30 May 2018
- Published by Luchevaya Diagnostika in Journal of radiology and nuclear medicine
- Vol. 99 (2) , 91-100
Open AccessPOSSIBILITIES OF MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING IN THE PERSONALIZATION OF SALVAGE RADIATION THERAPY IN PATIENTS WITH PROSTATE CANCER RECURRENCE
ВОЗМОЖНОСТИ МУЛЬТИПАРАМЕТРИЧЕСКОЙ МАГНИТНО-РЕЗОНАНСНОЙ ТОМОГРАФИИ В ПЕРСОНАЛИЗАЦИИ «СПАСИТЕЛЬНОЙ» ЛУЧЕВОЙ ТЕРАПИИ УБОЛЬНЫХ С РЕЦИДИВОМ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ